Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference3%
- Check18 days agoChange DetectedMinor updates: capitalization fix for the condition name and a version bump to v3.1.0. No significant content or critical data changes detected.SummaryDifference0.2%
- Check26 days agoChange Detected- Updated date references and identifiers: added 2025-09-15, 2025-09-08, 2025-09, and an estimated last update line; replaced the EU CT Number formatting and its reference. - Removed earlier date references (2025-04-16, 2025-04-11) and the explicit older EU CT Number (2024-516894-57-00), plus the older “Last Update Posted” wording.SummaryDifference1.0%
- Check33 days agoChange DetectedUpdated to Revision: v3.0.2 (from v3.0.1); removed the 'Back to Top' link; no other substantive content changes.SummaryDifference0.2%
- Check40 days agoChange DetectedThe page has been updated to include a new research article on improvements in health-related quality of life for patients with transfusion-dependent beta-thalassemia, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference3%
- Check47 days agoChange DetectedThe web page has been updated to include specific drug information for Exagamglogene Autotemcel and details about various genetic and blood disorders, while also removing some location-related terms and previous revision information.SummaryDifference6%
Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.